TSS
NAGE

Two Sigma Securities’s Niagen Bioscience NAGE Stock Holding History

Two Sigma Securities’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,851
Closed -$69.1K – 3811
2024
Q1 		$69.1K Buy
+19,851
New +$36.7K ﹤0.01% 2529
2023
Q2 		– Sell
-45,688
Closed -$69.9K – 3462
2023
Q1 		$69.9K Buy
+45,688
New +$81.3K ﹤0.01% 2242
2017
Q4 		– Sell
-12,813
Closed -$55K – 2062
2017
Q3 		$55K Buy
+12,813
New +$46.8K 0.01% 733

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Two Sigma Securities's NAGE Position: Q2 2024 in Review

Two Sigma Securities sold out of Niagen Bioscience (NAGE) in Q2 2024, closing a stake of 19,851 shares — an estimated $69.1K sold.

Two Sigma Securities first reported a position in NAGE in Q3 2017 and held it in 3 quarters. The position peaked at $69.9K in Q1 2023. 78 funds tracked by Wall St. Rank hold NAGE as of Q2 2024.

  • Two Sigma Securities reported no remaining Niagen Bioscience position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 19,851 Niagen Bioscience shares in Q2 2024, an estimated $69.1K.
  • Two Sigma Securities first reported a position in Niagen Bioscience in Q3 2017 and held it in 3 quarters.
  • Two Sigma Securities's Niagen Bioscience position peaked at $69.9K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.